Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1461 studies found for:    "familial atrial fibrillation" OR "Atrial Fibrillation"
Show Display Options
Rank Status Study
21 Completed Atrial Fibrillation Ablation Pilot Study
Condition: Atrial Fibrillation
Intervention: Procedure: Ablation procedure and/or cardioversion
22 Terminated Comparison of Treatment of Atrial Fibrillation (AF) Between Surgical Ultrasonic Technology or Drug Therapy for Patients With AF Requiring Mitral Valve Surgery
Conditions: Mitral Valvulopathy;   Atrial Fibrillation
Interventions: Device: EPICOR;   Drug: Amiodarone
23 Completed A Trial of Circumferential Pulmonary Vein Ablation (CPVA) Versus Antiarrhythmic Drug Therapy in for Paroxysmal Atrial Fibrillation (AF)
Condition: Atrial Fibrillation
Interventions: Procedure: Circumferential Pulmonary Vein Ablation;   Drug: Antiarrhythmic Drug Therapy
24 Recruiting Augmented Wide Area Circumferential Catheter Ablation for Reduction of Atrial Fibrillation Recurrence
Condition: Atrial Fibrillation
Interventions: Procedure: Wide area circumferential catheter ablation;   Procedure: Augmented- wide area circumferential ablation procedure
25 Recruiting Swiss Atrial Fibrillation Cohort Study
Condition: Atrial Fibrillation
Intervention:
26 Completed
Has Results
Atrial Fibrillation Without Hemodynamic Instability in the Intensive Care Unit
Condition: Atrial Fibrillation
Interventions: Drug: amiodarone;   Drug: Placebo
27 Unknown  Atrial Fibrillation and the Risk for Neurological Complications
Condition: Atrial Fibrillation
Intervention:
28 Completed
Has Results
THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation
Conditions: Heart Diseases;   Arrhythmia;   Atrial Fibrillation
Intervention: Device: THERMOCOOL® SMARTTOUCH™ Catheter
29 Unknown  Organization of Excitation in People With Atrial Fibrillation
Condition: Atrial Fibrillation
Intervention:
30 Recruiting Pulmonary Vein Isolation Versus Botulinum Toxin Injection Plus Pulmonary Vein Isolation in Patients With Atrial Fibrillation
Conditions: Paroxysmal Atrial Fibrillation;   Persistent Atrial Fibrillation
Interventions: Procedure: Pulmonary vein isolation;   Drug: Botulinum Toxin
31 Recruiting Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: Interrupted apixaban;   Drug: Uninterrupted apixaban
32 Completed
Has Results
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation
Conditions: Heart Diseases;   Arrhythmia;   Atrial Fibrillation
Interventions: Device: NAVISTAR® THERMOCOOL® Catheter;   Drug: Antiarrhythmic drug
33 Recruiting Atrial Fibrillation Prediction Trial.
Condition: Atrial Fibrillation
Intervention:
34 Completed
Has Results
Concomitant Utilization of Radio Frequency Energy for Atrial Fibrillation (CURE-AF) Study
Condition: Atrial Fibrillation
Interventions: Device: Cardioblate System Surgical Ablation System;   Procedure: Surgical RF Ablation
35 Withdrawn Atrial Fibrillation Screening With a Smartphone Device and iECG Application
Condition: Atrial Fibrillation
Intervention: Other: AF screening
36 Unknown  Atrial Fibrillation Rate Control Therapy Guided By Continuous Ambulatory Monitoring
Condition: Atrial Fibrillation
Intervention: Device: Mobile Cardiac Outpatient Telemetry
37 Completed
Has Results
Medtronic Concomitant Utilization of Radio Frequency for Atrial Fibrillation CURE-AF/Persistent
Condition: Atrial Fibrillation
Interventions: Device: Cardioblate Surgical Ablation System;   Procedure: Surgical RF Ablation
38 Terminated Catheter Ablation Versus Thoracoscopic Ablation to Patients With Permanent Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Procedure: Catheter ablation;   Procedure: Thoracoscopic epicardial ablation
39 Recruiting Atrial Fibrillation Detected by Continuous ECG Monitoring
Conditions: Atrial Fibrillation;   Stroke;   Hypertension;   Diabetes
Intervention: Device: LOOP recorder (Medtronic LINQ device)
40 Terminated The Use of DIOVAN to Reduce Post-Cardioversion Recurrence of Atrial Fibrillation Trial (the DRAFT Trial)
Condition: Atrial Fibrillation
Intervention: Drug: valsartan

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years